Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis

Hepatology

Volumn 34, Issue 2, 2001, Pages 273-282

  Chiaramonte, Monica G ^a   Cheever, Allen W ^b   Malley, James D ^a   Donaldson, Debra D ^c   Wynn, Thomas A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRIN FORMATION; IMMUNE RESPONSE; INBRED STRAIN; INFLAMMATION; LIVER FIBROSIS; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH2 CELL;

EID: 0034923170     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.26376     Document Type: Article

References (60)

1. The role of cytokines in human lung fibrosis
2. Subepithelial fibrosis in the bronchi of asthmatics
3. Viruses and idiopathic pulmonary fibrosis
4. Hepatic fibrogenesis and hepatitis C
5. Alcoholic liver disease: New insights in pathogenesis lead to new treatments
6. Schistosomiasis as a worldwide problem: Pathology
7. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis
8. The cell-mediated response to schistosomal antigens at the clonal level: Development and characterization of a panel of egg antigen-specific murine T cell clones
9. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response
10. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease
11. Th1 and Th2 responses regulate experimental lung granuloma development
12. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
13. γ-interferon treatment inhibits collagen deposition in murine schistosomiasis
14. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis
15. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile
16. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent
17. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses
18. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts
19. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
20. Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni
21. A distinct role for interleukin-13 in Th2-cell-mediated immune responses
22. The murine IL-13 receptor alpha 2: Molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1
23. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance
24. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs
25. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline
26. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni
27. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis
28. Immunoregulation of granuloma formation in murine schistosomiasis mansoni
29. Granuloma formation around Schistosoma mansoni, S. Haematobium, and S. Japonicum eggs: Size and rate of development, cellular composition, cross-reactivity, and rate of egg destruction
30. Receptors and cytokines involved in allergic TH2 cell responses
31. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents
32. Schistosoma mansoni in IL-4-deficient mice
33. Induction of interleukin-4-dependent IgE synthesis and interleukin-5-dependent eosinophil differentiation by supernatants of a human helper T-cell clone
34. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells
35. Immune responsiveness and the pathogenesis of human onchocerciasis
36. Basophils and mast cells in airway inflammation and asthma
37. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma
38. Mechanisms of eosinophil-associated inflammation
39. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni
40. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation
41. Gammainterferon inhibits collagen synthesis in vivo in the mouse
42. The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model
43. Ameliorating effect of an interferon inducer polyinosinicpolycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence
44. Introduction of the interleukin-10 gene into mice inhibited bleomycininduced lung injury in vivo
45. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
46. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis
47. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis
48. IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic disease
49. Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells
50. The initiation and function of Th2 responses during infection with Schistosoma mansoni
51. The purification, characterization, serological activity and hepatotoxic properties of two cationic glycoproteins (alpha 1 and omega 1) from Schistosoma mansoni eggs
52. Evolution of the schistosomal hepatic lesions in mice after curative chemotherapy
53. Liver fibrosis
54. Lung fibrosis
55. A role for C-C chemokines in fibrotic lung disease
56. Airway remodeling in asthma
57. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
58. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2
59. An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist
60. TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target?